Industry News
Skin Cancer Self Exam By Use Of Mobile App
Jul 12, 2012
Each year, over 2 million people in the U.S. are diagnosed with skin cancer. 50,000 of these will be diagnosed with melanoma, the most serious type of skin cancer. Regular skin checks can assist in detecting melanoma in its earliest stages. Cancer screening has just gone mobile with a new free app called UMSkinCheck, downloadable on iTunes... Read More
Breast Cancer Molecular "Post-It-Note" Warns Of Metastasis Spread Risk
Jul 12, 2012
According to a new report published in the BJC (British Journal of Cancer), a molecular "post-it note" added to breast cancer genes could identify the risk that the disease will spread in patients... Read More
Breast Cancer Molecular "Post-It-Note" Warns Of Metastasis Spread Risk
Jul 12, 2012
According to a new report published in the BJC (British Journal of Cancer), a molecular "post-it note" added to breast cancer genes could identify the risk that the disease will spread in patients... Read More
Chickens May Provide Clues For Battling Cancer
Jul 12, 2012
International researchers have discovered that a common chicken could provide some very un-common clues for tackling diseases. The study, published in the latest issue of Proceedings of the National Academy of Scientists, might even offer new ways to attack cancer... Read More
Targeting Cancer With Decreased Toxicity: First-Of-Its-Kind Approach To Designing Nanomedicines
Jul 12, 2012
Researchers at Brigham and Women's Hospital (BWH) are the first to report a new approach that integrates rational drug design with supramolecular nanochemistry in cancer treatment. Supramolecular chemistry is the development of complex chemical systems using molecular building blocks... Read More
New Breast Cancer Treatment Available In France
Jul 12, 2012
Reimbursement granted for Halaven® (eribulin) for women with locally advanced or metastatic breast cancer Halaven® (eribulin), a novel treatment for patients with locally advanced or metastatic breast cancer who have progressed after at least two chemotherapeutic regimens for advanced disease, has today received reimbursement approval from the French health authorities... Read More
New Breast Cancer Treatment Available In France
Jul 12, 2012
Reimbursement granted for Halaven® (eribulin) for women with locally advanced or metastatic breast cancer Halaven® (eribulin), a novel treatment for patients with locally advanced or metastatic breast cancer who have progressed after at least two chemotherapeutic regimens for advanced disease, has today received reimbursement approval from the French health authorities... Read More
Metastatic Breast Cancer: Bevacizumab Slows Progression, But Has No Impact On Survival
Jul 12, 2012
The cancer drug bevacizumab (Avastin®) offers only a modest benefit in prolonging disease progression in patients with advanced stage breast cancer, according to a systematic review by Cochrane researchers... Read More
In Bone Marrow Transplant Patients, Maraviroc Reduces Graft-Vs.-Host Disease
Jul 12, 2012
An HIV drug that redirects immune cell traffic significantly reduces the incidence of a dangerous complication that often follows bone marrow transplants for blood cancer patients, according to research from the Perelman School of Medicine at the University of Pennsylvania, published in the New England Journal of Medicine... Read More
Yissum Introduces A Novel Method For Treating Cancer Based On A Protein Encoded By HIV-1
Jul 12, 2012
The novel method uses a peptide derived from HIV to increase the sensitivity of cancer cells to radiotherapy and chemotherapy - Finding published in Blood, journal of the American society of hematology... Read More
Previous Page Next Page